市场快讯——美股行情动态-Boost Run、Nektar Therapeutics、Swarmer

路透中文
Aug 14
市场快讯——美股行情动态-Boost Run、Nektar <a href="https://laohu8.com/S/LENZ">Therapeutics</a>、Swarmer

工作区中用于查询单只股票行情的搜索字符串:STXBZ

《今日展望》通讯:https://refini.tv/3LI4BU7

《晨间新闻简报》:https://refini.tv/3dKUyB8

路透8月14日 - 周五,美国股指期货整体表现平淡。此前一天,标普500指数 .SPX 收于历史新高,但受中东局势最新进展推动原油价格上涨的影响,投资者仍保持谨慎态度。.N

** Valneva SE VALN.O:热点 - 欧盟监管机构确认受理莱姆病疫苗申请后股价飙升 nL6N44B0HO

** SAP SE SAP.N:热点 - 路透报道Silver Lake与Workday正在洽谈收购事宜后,欧洲软件股集体上涨 nL8N44B0BT

** 应用材料公司 (Applied Materials Inc) AMAT.O:热点 - 尽管前景乐观,但未能打动投资者,股价下跌 nL4N44B0I0

** Unusual Machines Inc UAMC.N:

** 红猫控股公司 RCAT.O:

** 航空环境公司(Aerovironment Inc) AVAV.O:

** 奥瑞斯格林威控股公司 PUSA.O:热点 - 特朗普宣布对无人机进口加征关税,美国无人机企业股价上涨 nL4N44B0JX

** Reddit Inc RDDT.N:热点 - 因即将被纳入标普500指数而股价飙升 nL6N44B0MV

** Capricor Therapeutics Inc CAPR.O:热点 - FDA同意审查新的杜氏肌营养不良症药物数据,股价翻倍有余 nL4N44B0NP

** Zentalis Pharmaceuticals Inc ZNTL.O:热点 - 因8100万美元股票出售而下跌 nL6N44B0P2

** 福克斯公司(Fox Corp) FOXA.O:热点 - 摩根大通将福克斯评级上调至“增持”,股价上涨 nL4N44B0O9

** 比肯斯托克控股公司(Birkenstock Holding PLC) BIRK.N:热点——受L Catterton抛售10亿美元股份影响,股价下跌 nL6N44B0PH

** RLX Technology Inc RLX.N:市场动态 - 因成本上升拖累季度利润,股价下跌 nL6N44B0OE

** 伊顿制药公司(Eton Pharmaceuticals Inc) ETON.O:热点 - 因第二季度盈利超预期而上涨 nL6N44B0PW

** Nektar Therapeutics NKTR.O:市场动态 - 因季度营收未达预期而下跌 nL4N44B0Q3

** Nu Holdings Ltd NU.N:热点 - 因第二季度业绩超预期而大涨 nL6N44B0P3

** Swarmer Inc SWMR.O:市场动态 - 在首次公开募股(IPO)后的首份财报中,因第二季度亏损扩大而下跌 nL6N44B0QO

** Gemini Space Station Inc GEMI.O:热点 - 因第二季度亏损额超出预期而下跌 nL6N44B0RG

** Boost Run Inc BRUN.O:热点 - 受第二季度营收大幅增长提振,股价上涨 nL4N44B0SR

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10